Results 191 to 200 of about 70,730 (308)

Mycobacterium tuberculosis complex DNA from an extinct bison dated 17,000 years before the present [PDF]

open access: yes, 2001
Bar-Gal, GK   +8 more
core   +1 more source

Immune endotypes in tuberculosis: Keys to decoding disease complexity

open access: yesJournal of Internal Medicine, Volume 299, Issue 6, Page 670-693, June 2026.
Abstract Tuberculosis (TB) remains a major global health challenge, with multi‐drug antibiotic regimens as the current standard of care. While effective at killing Mycobacterium tuberculosis, these treatments do not resolve persistent inflammation, prevent lung damage, or reverse immune dysregulation that contribute to poor outcomes and disease ...
Shamila D. Alipoor   +4 more
wiley   +1 more source

Identifying and Quantifying Conflicts Between Humans and Terrestrial Mammals in Great Britain

open access: yesMammal Review, Volume 56, Issue 2, June 2026.
We conducted a literature review to identify conflicts between humans and terrestrial mammals in Great Britain. A modified Generic Impact Scoring System was applied to all conflicts so that mammals could be ranked according to their level of impact to help identify the most damaging species and to aid decision‐making. ABSTRACT Introduction Interactions
Kate L. Palphramand   +3 more
wiley   +1 more source

Functional analysis of type VII secretion system links to host immune evasion mechanism in <i>Mycobacterium tuberculosis</i>. [PDF]

open access: yesFront Cell Infect Microbiol
Sundaram K   +5 more
europepmc   +1 more source

Management of Tuberculosis: Manual for Health Workers [PDF]

open access: yes, 2003
Ministry of Health and Social Welfare, (MHSW)
core  

Pharmacokinetics of dolutegravir, tenofovir and lamivudine during venous–venous extracorporeal membrane oxygenation (VV‐ECMO): A case report

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 5, Page 1487-1492, May 2026.
While providing potentially life‐saving cardiorespiratory support for critically ill patients, extracorporeal membrane oxygenation (ECMO) may detrimentally affect pharmacokinetic (PK) performance and concurrent drug efficacy and safety. We describe a patient with Pneumocystis jirovecii pneumonia (PJP) in the context of acquired immunodeficiency ...
Tom C. Zwart   +7 more
wiley   +1 more source

Occupational Transmission of Extensively Drug-Resistant Tuberculosis, France. [PDF]

open access: yesEmerg Infect Dis
Poignon C   +8 more
europepmc   +1 more source

Quality by Design‐Based Development of a Robust LC Method for Simultaneous Estimation of Process‐ and Degradation‐Related Impurities in Rifapentine Drug Product for the Treatment of Active and Latent Tuberculosis

open access: yesBiomedical Chromatography, Volume 40, Issue 5, May 2026.
ABSTRACT A precise, robust, and stability‐indicating liquid chromatographic (LC) method coupled with a photodiode array (PDA) detector was developed and validated for the quantitative estimation of rifapentine, an essential therapeutic agent for both active and latent tuberculosis (TB).
Siva Prasad Korikana   +5 more
wiley   +1 more source

Tuberculous Endophthalmitis With Phthisis Bulbi: A Diagnostic Delay Case Report

open access: yesClinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Tuberculous endophthalmitis should be prioritized in differential diagnosis for unexplained endophthalmitis in TB‐endemic regions; early systemic evaluation, timely pars plana vitrectomy, and adjunctive corticosteroids are crucial to prevent phthisis bulbi, though evidence for some interventions remains limited.
Yanchen Chen   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy